A major NICE update: why infective endocarditis prevention is back on the agenda

A major NICE update: why infective endocarditis prevention is back on the agenda

UK guidance on infective endocarditis (IE) prevention has undergone its most significant change in nearly two decades, and every dentist needs to understand what it means for their clinical practice.

IE is a serious infection of the heart valves. Some 30% of patients die within one year of diagnosis, and survivors face significant long-term health problems (Cahill and Prendergast, 2015). Oral bacteria are implicated in 35-45% of IE cases (Thornhill et al, 2024).

Before 2008, UK guidelines recommended antibiotic prophylaxis (AP) before invasive dental procedures for all patients at increased IE risk. 

In 2008, NICE made the contested decision to recommend against all use of AP for IE prevention, stating: ‘Antibiotic prophylaxis against infective endocarditis is not recommended for people undergoing dental procedures.’ Dentists working for the NHS in England and Wales were contractually required to follow NICE guidance, and compliance was high (Dayer et al, 2015).

Sign in to continue reading

This content is exclusive to members of

Sign up

Already a member? Sign in here

Free access to our premium content:

  • Clinical content
  • In-depth analysis
  • Features, reports, videos and more

By joining, you’re helping to support independent, quality journalism that keeps dental professionals informed and empowered – and allowing us to keep delivering the insights you value most.

Favorite
Get the most out of your membership by subscribing to Dentistry CPD
  • Access 600+ hours of verified CPD courses
  • Includes all GDC recommended topics
  • Powerful CPD tracking tools included
Register for webinar

Stay updated with relevant information about this webinar

Share
Add to calendar